Vitamin D in ischemic stroke

Not Applicable

Recruiting

• Conditions: Ischemic stroke.; Cerebral infarction

• Registration Number: IRCT20170104031773N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 March 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with vitamin D deficiency (less than 20 ng per ml)
Patients with moderate acute stroke based on the NIHSS scoring system

Exclusion Criteria

The serum level of vitamin D is above 20 ng per ml
Receive antioxidants (such as vitamins C and E) continuously
Receive continuous anti-inflammatory drugs (steroids-NSAIDs)
AIDS and neurodegenerative diseases (such as Alzheimer's, Parkinson's, ALS, MS
Systemic diseases like, Diabetes Mellitus, Kidney Failure, Malignant Melanoma, Uremia, Liver Cirrhosis and Chronic Myocardial Infarction, Myopathy
Change in mental status with unknown etiology

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The level of Tumor necrosis factor alpha. Timepoint: At the beginning of the study (before the intervention), 1 month after the start of taking vitamin D. Method of measurement: Blood sample.;The level of Interleukin 6. Timepoint: At the beginning of the study (before the intervention), 1 month after the start of taking vitamin D. Method of measurement: Blood sample.;The level of vitamin D. Timepoint: At the beginning of the study (before the intervention), 1 month after the start of taking vitamin D. Method of measurement: Blood Sample.

Secondary Outcome Measures

Name	Time	Method
ational Institues of Health Stroke Scale Measurement. Timepoint: At the beginning of the study (before the intervention), 1 and 3 months after the start of taking vitamin D. Method of measurement: National Institues of Health Stroke Scale Questionnaire.;Measuring Mini Mental State Examination. Timepoint: At the beginning of the study (before the intervention), 1 and 3 months after the start of taking vitamin D. Method of measurement: Mini Mental State Examination Questionnaire.;Measuring Modified Rankin Scale. Timepoint: At the beginning of the study (before the intervention), 1 and 3 months after the start of taking vitamin D. Method of measurement: Modified Rankin Scale Questionnaire.